Drug Database
Back to search

United States· US:50228-379_1ab4be5f-4926-88ad-e063-6294a90a0c81

Ezetimibe

A ezetimibe product containing ezetimibe, registered in United States by ScieGen Pharmaceuticals Inc. The same ATC class is registered in 17 of our 19 countries.

ATC C10AX09US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedEzetimibeATCC10AX09REGISTER NO.US:50228-379_1ab4be5f…PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ezetimibeAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ezetimibe is registered in 17 of 19 countries.

Countries holding a registration under ATC C10AX09 (ezetimibe), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search ezetimibe products by name

Ezetimibe · ATC C10AX09

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ezetimibe costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.067 in United States to $1.32 in Switzerland — a ×20 gap.

  • United States: $0.067 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Ezetimibe · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.32
  • IT Italy$0.80
  • FR France$0.45
  • US United States$0.067 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EZETIMIBE
Manufacturer
ScieGen Pharmaceuticals Inc
Country
United States (US)
ATC code
C10AX09
ATC class
Ezetimibe
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    5022837905
    500 TABLET in 1 BOTTLE (50228-379-05)
  • ndc11
    5022837910
    1000 TABLET in 1 BOTTLE (50228-379-10)
  • ndc11
    5022837930
    30 TABLET in 1 BOTTLE (50228-379-30)
  • ndc11
    5022837990
    90 TABLET in 1 BOTTLE (50228-379-90)
  • ndc11
    50228-379-05
  • ndc11
    50228-379-10
  • ndc11
    50228-379-30
  • ndc11
    50228-379-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for ezetimibe.

Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ezetimibe against other medicinesHow interaction checks work

Ezetimibe · interactions on record

236 records

  • 23 moderate
  • 2 minor
  • 210 info

Most severe, free to view

  • Chenodeoxycholic acidA05AA01moderate
  • EluxadolineA07DA06moderate
  • EltrombopagB02BX05moderate
  • SimvastatinC10AA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ezetimibe in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ezegelan, Ezetimib +pharma
  • Belgium · Ezetimib Ab, Ezetimibe Eg
  • Bulgaria · Езен, Езетимиб Адамед
  • Cyprus · Erezel, Ezetimibe Accord
  • Czechia · Egitim, Ezen
  • Germany · Ezetad, Ezetimib 1 A Pharma
  • Denmark · Carditimib, Cildar
  • Estonia · Ezetimibe Accord, Ezetimibe Elvim
  • Spain · Absorcol, Azibe
  • Finland · Ezetimib Krka, Ezetimib Liconsa
  • France · Ezetimibe Accord, Ezetimibe Almus
  • United Kingdom (Northern Ireland) · Ezetimibe, Ezetimibe 10mg
  • Greece · Cildar, Delipid
  • Croatia · Elanix, Ezetrol
  • Hungary · Coltowan, Ezetimib Egis
  • Ireland · Ezetimibe Accord Healthcare Ireland, Ezetimibe Krka
  • Iceland · Ezetimib Actavis, Ezetimib Krka
  • Italy · Absorcol, Corintus
  • Lithuania · Coltowan, Ezetimibe Elvim
  • Luxembourg · Ezetimib Ratiopharm, Ezetimibe Eg
  • Latvia · Ezetimibe Accord, Ezetimibe Elvim
  • Malta · Ezetimibe Msn, Ezoleta
  • Netherlands · Ezdivule, Ezetimibe Accord
  • Norway · Ezetimib Actavis, Ezetimib Krka
  • Poland · Coltowan, Etibax
  • Portugal · Ezetimiba Alter, Ezetimiba Aristo
  • Romania · Cexado, Coltowan
  • Sweden · Ezetimib Actavis, Ezetimib Krka
  • Slovenia · Elanix, Ezetrol
  • Slovakia · Ezen, Ezetimib Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b91a246f-d0fa-4d47-af0b-d1fd681da83d
GET /v1/drugs/b91a246f-d0fa-4d47-af0b-d1fd681da83d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "EZETIMIBE",
  "productndc": "50228-379",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA210673",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console